Insulin resistance postburn

Underlying mechanisms and current therapeutic strategies

Gerd G. Gauglitz, David Herndon, Marc G. Jeschke

Research output: Contribution to journalArticle

63 Citations (Scopus)

Abstract

The profound hypermetabolic response to burn injury is associated with insulin resistance and hyperglycemia, significantly contributing to the incidence of morbidity and mortality in this patient population. These responses are present in all trauma, surgical, or critically ill patients, but the severity, length, and magnitude is unique for burn patients. Although advances in therapeutic strategies to attenuate the postburn hypermetabolic response have significantly improved the clinical outcome of these patients during the past years, therapeutic approaches to overcome stress-induced hyperglycemia have remained challenging. Intensive insulin therapy has been shown to significantly reduce morbidity and mortality in critically ill patients. High incidence of hypoglycemic events and difficult blood glucose titrations have led to investigation of alternative strategies, including the use of metformin, a biguanide, or fenofibrate, a peroxisome proliferator-activated receptor (PPAR)-γ agonist. Nevertheless, weaknesses and potential side affects of these drugs reinforces the need for better understanding of the molecular mechanisms underlying insulin resistance postburn that may lead to novel therapeutic strategies further improving the prognosis of these patients. This review aims to discuss the mechanisms underlying insulin resistance induced hyperglycemia postburn and outlines current therapeutic strategies that are being used to modulate hyperglycemia after thermal trauma.

Original languageEnglish (US)
Pages (from-to)683-694
Number of pages12
JournalJournal of Burn Care and Research
Volume29
Issue number5
DOIs
StatePublished - Sep 2008

Fingerprint

Insulin Resistance
Hyperglycemia
Critical Illness
Wounds and Injuries
Therapeutics
Biguanides
Fenofibrate
Morbidity
Peroxisome Proliferator-Activated Receptors
Mortality
Metformin
Incidence
Hypoglycemic Agents
Blood Glucose
Hot Temperature
Insulin
Pharmaceutical Preparations
Population

ASJC Scopus subject areas

  • Emergency Medicine
  • Rehabilitation
  • Surgery

Cite this

Insulin resistance postburn : Underlying mechanisms and current therapeutic strategies. / Gauglitz, Gerd G.; Herndon, David; Jeschke, Marc G.

In: Journal of Burn Care and Research, Vol. 29, No. 5, 09.2008, p. 683-694.

Research output: Contribution to journalArticle

Gauglitz, Gerd G. ; Herndon, David ; Jeschke, Marc G. / Insulin resistance postburn : Underlying mechanisms and current therapeutic strategies. In: Journal of Burn Care and Research. 2008 ; Vol. 29, No. 5. pp. 683-694.
@article{2483f1a95d9d4474b8ae820671795832,
title = "Insulin resistance postburn: Underlying mechanisms and current therapeutic strategies",
abstract = "The profound hypermetabolic response to burn injury is associated with insulin resistance and hyperglycemia, significantly contributing to the incidence of morbidity and mortality in this patient population. These responses are present in all trauma, surgical, or critically ill patients, but the severity, length, and magnitude is unique for burn patients. Although advances in therapeutic strategies to attenuate the postburn hypermetabolic response have significantly improved the clinical outcome of these patients during the past years, therapeutic approaches to overcome stress-induced hyperglycemia have remained challenging. Intensive insulin therapy has been shown to significantly reduce morbidity and mortality in critically ill patients. High incidence of hypoglycemic events and difficult blood glucose titrations have led to investigation of alternative strategies, including the use of metformin, a biguanide, or fenofibrate, a peroxisome proliferator-activated receptor (PPAR)-γ agonist. Nevertheless, weaknesses and potential side affects of these drugs reinforces the need for better understanding of the molecular mechanisms underlying insulin resistance postburn that may lead to novel therapeutic strategies further improving the prognosis of these patients. This review aims to discuss the mechanisms underlying insulin resistance induced hyperglycemia postburn and outlines current therapeutic strategies that are being used to modulate hyperglycemia after thermal trauma.",
author = "Gauglitz, {Gerd G.} and David Herndon and Jeschke, {Marc G.}",
year = "2008",
month = "9",
doi = "10.1097/BCR.0b013e31818481ce",
language = "English (US)",
volume = "29",
pages = "683--694",
journal = "Journal of Burn Care and Research",
issn = "1559-047X",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Insulin resistance postburn

T2 - Underlying mechanisms and current therapeutic strategies

AU - Gauglitz, Gerd G.

AU - Herndon, David

AU - Jeschke, Marc G.

PY - 2008/9

Y1 - 2008/9

N2 - The profound hypermetabolic response to burn injury is associated with insulin resistance and hyperglycemia, significantly contributing to the incidence of morbidity and mortality in this patient population. These responses are present in all trauma, surgical, or critically ill patients, but the severity, length, and magnitude is unique for burn patients. Although advances in therapeutic strategies to attenuate the postburn hypermetabolic response have significantly improved the clinical outcome of these patients during the past years, therapeutic approaches to overcome stress-induced hyperglycemia have remained challenging. Intensive insulin therapy has been shown to significantly reduce morbidity and mortality in critically ill patients. High incidence of hypoglycemic events and difficult blood glucose titrations have led to investigation of alternative strategies, including the use of metformin, a biguanide, or fenofibrate, a peroxisome proliferator-activated receptor (PPAR)-γ agonist. Nevertheless, weaknesses and potential side affects of these drugs reinforces the need for better understanding of the molecular mechanisms underlying insulin resistance postburn that may lead to novel therapeutic strategies further improving the prognosis of these patients. This review aims to discuss the mechanisms underlying insulin resistance induced hyperglycemia postburn and outlines current therapeutic strategies that are being used to modulate hyperglycemia after thermal trauma.

AB - The profound hypermetabolic response to burn injury is associated with insulin resistance and hyperglycemia, significantly contributing to the incidence of morbidity and mortality in this patient population. These responses are present in all trauma, surgical, or critically ill patients, but the severity, length, and magnitude is unique for burn patients. Although advances in therapeutic strategies to attenuate the postburn hypermetabolic response have significantly improved the clinical outcome of these patients during the past years, therapeutic approaches to overcome stress-induced hyperglycemia have remained challenging. Intensive insulin therapy has been shown to significantly reduce morbidity and mortality in critically ill patients. High incidence of hypoglycemic events and difficult blood glucose titrations have led to investigation of alternative strategies, including the use of metformin, a biguanide, or fenofibrate, a peroxisome proliferator-activated receptor (PPAR)-γ agonist. Nevertheless, weaknesses and potential side affects of these drugs reinforces the need for better understanding of the molecular mechanisms underlying insulin resistance postburn that may lead to novel therapeutic strategies further improving the prognosis of these patients. This review aims to discuss the mechanisms underlying insulin resistance induced hyperglycemia postburn and outlines current therapeutic strategies that are being used to modulate hyperglycemia after thermal trauma.

UR - http://www.scopus.com/inward/record.url?scp=55249116335&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=55249116335&partnerID=8YFLogxK

U2 - 10.1097/BCR.0b013e31818481ce

DO - 10.1097/BCR.0b013e31818481ce

M3 - Article

VL - 29

SP - 683

EP - 694

JO - Journal of Burn Care and Research

JF - Journal of Burn Care and Research

SN - 1559-047X

IS - 5

ER -